Alnylam Pharmaceuticals Price Target Raised to $280.00/Share From $248.00 by JP Morgan
Alnylam Pharmaceuticals Price Target Raised to $280.00/Share From $248.00 by JP Morgan
阿里拉姆製藥的股票目標價從248.00美元上調至280.00美元,由摩根大通提出。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊